Stock Events

Stock Events

Kalvista Pharmaceuticals (KALV) Q3 2024 Earnings

5SepConfirmed

Q3 2023

Q1 2024

Q3 2024

Q3 2024

-1.02

-0.92

-0.82

-0.71

Details

Expected EPS

-0.915

Actual EPS

-0.87

Surprise EPS

0.05

Surprise Percent

+4.92%

Description

Kalvista Pharmaceuticals (KALV) has reported earnings of -0.87 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.